Objective: We are presenting a conceptually new approach involving the use of a self-made xeno-pericardial graft in combination with biological aortic valve prosthesis in patients with prosthetic endocarditis. Method: In case of proven prosthetic infective endocarditis after aortic root replacement our strategy includes complete explantation of the infected vascular prosthesis and valve, forming a new vascular tube from bovine pericardium corresponding to the dimensions of the aortic annulus and ascending aorta and sewing a new biological valve into it. The procedure was performed under short circulatory arrest with unilateral brain perfusion in mild hypothermia. Results: During surgery the aortic root, ascending aorta and hemiarch were replaced using a xenopericardial valved graft. The length of the stay in ICU and general ward was 24 days. No early and late neurological deficits were found. Follow Up time was 6 months. The course of antibiotic therapy was completed in 6 weeks. At the follow up no signs of repeated infection as well as structural changes of the valve were found. Conclusions: Implantation of self-made xenopericardial valved graft is an innovative strategy and represents a safe alternative for prosthetic infective endocarditis. The short-term results of this approach are excellent, although further studies are needed to confirm positive medium and long-term results in large cohorts. Self-made valved xenopericardial grafts are readily available, off the-shelf, easy to assemble and durable alternative for the replacement of all aortic segments from the root till arch.
Fujii T, Watanabe Y. Multidisciplinary treatment approach for prosthetic vascular graft infection in the thoracic aortic area. Ann Thorac Cardiovasc Surg 2015;21:418–27.
Vogel TR, Symons R,Flum DR.The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008; 47:264
Cernohorsky P, Reijnen MM, Tielliu IF, van Sterkenburg SM, van den Dungen JJ, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg 2011; 54:327-33.
Odero A, Argenteri A, Cugnasca M, Pirrelli S. The crimped bovine pericardium bioprosthesis in graft infection: preliminary experience. Eur J Vasc Endovasc Surg 1997;14:99e101.
McMillan WD, Leville CD, Hile CN. Bovine pericardial patch repair in infected fields. J Vasc Surg 2012;55:1712e5.
Czerny M, von Allmen R, Opfermann P, Sodeck G, Dick F, Stellmes A, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg 2011;92: 1657e62.
Nappi F, Nenna A, Petitti T, Spadaccio C, Gambardella I, Lusini M et al. Long-term outcome of cryopreserved allograft for aortic valve replacement. J Thorac Cardiovasc Surg 2018;156:1357–65.e6.
Umminger J, Krueger H, Beckmann E, Kaufeld T, Fleissner F, Haverich A et al. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. Eur J Cardiothorac Surg 2016;50:660–7.
Kondov S, Beyersdorf F, Rylski B, Kreibich M, Dimov A, Berger T et al. Redo aortic root repair in patients with infective prosthetic endocarditis using xenopericardial solutions. Interact CardioVasc Thorac Surg 2019;29:339–43.
Kowert A, Vogt F, Beiras-Fernandez A, Reichart B, Kilian E. Outcome afterhomograft redo operation in aortic position. Eur J Cardiothorac Surg2012;41:404–8.
Weiss S, Tobler EL, von Tengg-Kobligk H, Makaloski V, Becker D, Carrel TP et al. Self made xeno-pericardial aortic tubes to treatnative and aortic graft infections. Eur J Vasc Endovasc Surg 2017;54:646–52.
. Reineke DC, Kaya A, Heinisch PP, Oezdemir B, Winkler B, Huber C et al. Long-term follow-up after implantation of the ShelhighVR No-ReactVR complete biological aortic valved conduit. Eur J Cardiothorac Surg 2016; 50:98–104.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075–128.
Heubner L, Schneider U, Giebels C, Karliova I, Raddatz A, Schafers HJ. Early and long-term outcomes for patients undergoing reoperative aor- tic root replacement. Eur J Cardiothorac Surg 2019;55:232–7.
Wendt D, Raweh A, Knipp S, El Gabry M, Eißmann M, Dohle DS et al. Comparison of mid-term haemodynamic performance betweenthe BioValsalva and the BioIntegral valved conduits after aortic root replace- ment. Interact CardioVasc Thorac Surg 2016;23:112–17.
Xin Li, Yuanyuan Guo, Kenneth R. Ziegler, Lynn S. Model, Sammy D.D. Eghbalieh, Robert A. Brenes, Susun T. Kim, Chang Shu, Alan Dardik,Current Usage and Future Di-76 rections for the Bovine Pericardial Patch,Annals of Vascular Surgery, Volume 25, Issue 4,2011, Pages 561-568
A. Pupka, J. Skora, D. Janczak, T. Plonek, J. Marczak, T. Szydeko,In Situ Revascularisation with Silver-coated Polyester Prosthesesand Arterial Homografts in Patients with Aortic Graft Infection – A Prospective, Comparative, Singlecentre Study, European Journal of Vascular and Endovascular Surgery, Volume 41, Issue 1, 2011, Pages 61-67, ISSN 1078-5884
Kreibich M, Siepe M, Morlock J, Beyersdorf F, Kondov S, Scheumann J et al. Surgical treatment of native and prosthetic aortic infectionwith xenopericardial tube-grafts. Ann Thorac Surg 2018;106: 498–504.
Guenther SP, Reichelt A, Peterss S, Luehr M, Bagaev E, Hagl C et al. Root replacement for graft infection using an all-biologic xenopericardial conduit. J Heart Valve Dis 2016;25:440–7.